Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ransmayr

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Journal of Neural Transmission. Supplementum|January 1, 1994
The glycine binding site of the NMDA receptor: involvement in neurodegeneration and new approach for neuroprotectionJ Hartmann, G Ransmayr, P Riederer
Journal of Neural Transmission. Supplementum|January 1, 1992
Modern therapy of Parkinson's diseaseG Ransmayr, G Künig, F Gerstenbrand
Acta Neurologica Scandinavica. Supplementum|January 1, 1983
Deprenyl (selegiline) in combination treatment of Parkinson's diseaseF Gerstenbrand, G Ransmayr, W Poewe
Journal of Neural Transmission. Supplementum|January 1, 1987
Experience with selegiline in the treatment of Parkinson's diseaseW Poewe, F Gerstenbrand, G Ransmayr
Neurology|November 13, 2002
Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRIM Gerlach, K Stadler, F Aichner, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1994
NADPH-diaphorase/nitric oxide synthase containing neurons in normal and Parkinson's disease putamenR Böckelmann, G Wolf, G Ransmayr, et al.
Deutsche Medizinische Wochenschrift (1946)|October 4, 1991
[Orthostatic tremor]J Willeit, F Deisenhammer, G Ransmayr, et al.
Journal of Neural Transmission. Supplementum|January 1, 1983
Premorbid personality of Parkinson patientsW Poewe, F Gerstenbrand, G Ransmayr, et al.
The British Journal of Dermatology|February 25, 2005
CADASIL-an unusual manifestation with prominent cutaneous involvementG Ratzinger, G Ransmayr, N Romani, et al.
Advances in Neurology|January 1, 1987
Therapeutic experiences with an abeorphine derivative in Parkinson's diseaseG Birbamer, G Ransmayr, F Gerstenbrand, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Journal of Neural Transmission. Supplementum|January 1, 1994
The glycine binding site of the NMDA receptor: involvement in neurodegeneration and new approach for neuroprotectionJ Hartmann, G Ransmayr, P Riederer
Journal of Neural Transmission. Supplementum|January 1, 1992
Modern therapy of Parkinson's diseaseG Ransmayr, G Künig, F Gerstenbrand
Acta Neurologica Scandinavica. Supplementum|January 1, 1983
Deprenyl (selegiline) in combination treatment of Parkinson's diseaseF Gerstenbrand, G Ransmayr, W Poewe
Journal of Neural Transmission. Supplementum|January 1, 1987
Experience with selegiline in the treatment of Parkinson's diseaseW Poewe, F Gerstenbrand, G Ransmayr
Neurology|November 13, 2002
Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRIM Gerlach, K Stadler, F Aichner, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1994
NADPH-diaphorase/nitric oxide synthase containing neurons in normal and Parkinson's disease putamenR Böckelmann, G Wolf, G Ransmayr, et al.
Deutsche Medizinische Wochenschrift (1946)|October 4, 1991
[Orthostatic tremor]J Willeit, F Deisenhammer, G Ransmayr, et al.
Journal of Neural Transmission. Supplementum|January 1, 1983
Premorbid personality of Parkinson patientsW Poewe, F Gerstenbrand, G Ransmayr, et al.
The British Journal of Dermatology|February 25, 2005
CADASIL-an unusual manifestation with prominent cutaneous involvementG Ratzinger, G Ransmayr, N Romani, et al.
Advances in Neurology|January 1, 1987
Therapeutic experiences with an abeorphine derivative in Parkinson's diseaseG Birbamer, G Ransmayr, F Gerstenbrand, et al.
Pageof 8